Haemonetics (HAE) Receivables - Other (2012 - 2022)

Haemonetics has reported Receivables - Other for 7 years, with the latest figure at $6.6 million in Q4 2022.

• For the quarter ending Q4 2022, Receivables - Other rose 20.0% year-over-year to $6.6 million; the trailing twelve-month figure through Dec 2022 stood at $6.6 million (up 20.0% YoY), and the FY2022 full-year result was $5.5 million, up 14.58% from the prior year.
• Receivables - Other for Q4 2022 stood at $6.6 million, down from $7.6 million in the prior quarter.
• The five-year high for Receivables - Other was $10.5 million in Q4 2018, with the low at $4.0 million in Q2 2018.
• Average Receivables - Other over 5 years is $6.1 million, with a median of $5.6 million recorded in 2019.
• Year-over-year, Receivables - Other jumped 147.62% in 2018 and tumbled 34.33% in 2021.
• Tracing HAE's Receivables - Other over 5 years: stood at $10.5 million in 2018, then fell by 23.81% to $8.0 million in 2019, then plunged by 32.5% to $5.4 million in 2020, then declined by 18.52% to $4.4 million in 2021, then soared by 50.0% to $6.6 million in 2022.
• The last three Receivables - Other figures came in at $6.6 million (Q4 2022), $7.6 million (Q4 2022), and $6.4 million (Q3 2022), per Business Quant data.

Peer Comparison